Home > Market > Market Stats >  Dishman Carbogen Amcis

Dishman Carbogen Amcis

Sector: Biotechnology & Drugs
Powered by
97.30 +2.20 (2.31%)
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y

Price Range

Today’s Low 93.7
Today’s High 97.5
52 Week Low 90.2
52 Week High 259.5

Key Metrics

  • Market Cap (In Cr) 1487.09
  • Beta 1.85
  • Div. Yield (%) 0
  • P/B 0.27
  • TTM P/E 295.68
  • Peg Ratio 0.24
  • Sector P/E 37.72
  • D/E -
  • Open Price 94
  • Prev Close 95.1
View All Metrics on Mint Genie

Analysis

Price Analysis
  • 1 Week
    -6.14%
  • 3 Months
    -16.02%
  • 6 Month
    -48.66%
  • YTD
    -52.94%
  • 1 Year
    -52.13%
Risk Meter
  • 54% Low risk
  • 54% Moderate risk
  • 54% Balanced Risk
  • 54% High risk
  • 54% Extreme risk
Recos
2 Analysts
  • Strong Sell
  • Sell
  • Hold
  • Buy
  • Strong Buy
Analysts' Views
  • Ratings
  • Current
  • Strong Sell
  • 0
  • Sell
  • 0
  • Hold
  • 1
  • Buy
  • 1
  • Strong Buy
  • 0

Financials

  • INCOME
  • BALANCE SHEET
  • Cashflow
  • Period
  • 2022
  • Total Revenue
  • 2140.69
  • Selling/ General/ Admin Expenses Total
  • 1254.34
  • Depreciation/ Amortization
  • 307.59
  • Other Operating Expenses Total
  • 9.69
  • Total Operating Expense
  • 2125.46
  • Operating Income
  • 15.23
  • Net Income Before Taxes
  • -4.25
  • Net Income
  • 18.01
  • Diluted Normalized EPS
  • 8.24
  • Period
  • 2021
  • Total Revenue
  • 1912.03
  • Selling/ General/ Admin Expenses Total
  • 1090.79
  • Depreciation/ Amortization
  • 307.66
  • Other Operating Expenses Total
  • 6.04
  • Total Operating Expense
  • 1951.71
  • Operating Income
  • -39.68
  • Net Income Before Taxes
  • -65.03
  • Net Income
  • -165.13
  • Diluted Normalized EPS
  • -3.97
  • Period
  • 2020
  • Total Revenue
  • 2043.6
  • Selling/ General/ Admin Expenses Total
  • 981.39
  • Depreciation/ Amortization
  • 282.62
  • Other Operating Expenses Total
  • 11.61
  • Total Operating Expense
  • 1811.2
  • Operating Income
  • 232.4
  • Net Income Before Taxes
  • 197.2
  • Net Income
  • 158.51
  • Diluted Normalized EPS
  • 15.35
  • Period
  • 2019
  • Total Revenue
  • 2058.59
  • Selling/ General/ Admin Expenses Total
  • 959.3
  • Depreciation/ Amortization
  • 240.38
  • Other Operating Expenses Total
  • 10.71
  • Total Operating Expense
  • 1723.97
  • Operating Income
  • 334.62
  • Net Income Before Taxes
  • 308.79
  • Net Income
  • 210.33
  • Diluted Normalized EPS
  • 16.77
  • Period
  • 2018
  • Total Revenue
  • 1694.78
  • Selling/ General/ Admin Expenses Total
  • 793.63
  • Depreciation/ Amortization
  • 211.21
  • Other Operating Expenses Total
  • 12.17
  • Total Operating Expense
  • 1443.65
  • Operating Income
  • 251.13
  • Net Income Before Taxes
  • 230.79
  • Net Income
  • 154.57
  • Diluted Normalized EPS
  • 15
  • Period
  • 2017
  • Total Revenue
  • 1713.69
  • Selling/ General/ Admin Expenses Total
  • 864.21
  • Depreciation/ Amortization
  • 213.31
  • Other Operating Expenses Total
  • 1.36
  • Total Operating Expense
  • 1472.28
  • Operating Income
  • 241.41
  • Net Income Before Taxes
  • 216.08
  • Net Income
  • 145.43
  • Diluted Normalized EPS
  • 14.65
View detailed financials on Mint Genie

Forecast

Income Sheet (In Cr) Net Income Vs Revenue
Returns Metrics (In Cr) ROA Vs ROE

Technical

Moving Average SMA
  • 5 Day95.6
  • 10 Day99.57
  • 20 Day108.13
  • 50 Day116.11
  • 100 Day117.75
  • 300 Day155.89

Peers

  • Price
  • Ratio
  • Name
  • Latest Price
  • Change
  • % Change
  • 52W High
  • 52W Low
  • Mkt. Cap
  • Alembic
  • 66
  • 4.45
  • 7.23
  • 118.4
  • 56.5
  • 1584.34

Corporate Actions

  • Board Meeting
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
  • Meeting Date
  • Purpose
  • 09-Aug-22
  • Quarterly Results
  • 10-May-22
  • Audited Results
  • 03-Feb-22
  • Quarterly Results
  • 28-Oct-21
  • Quarterly Results
  • 12-Aug-21
  • Quarterly Results
  • 16-Jun-21
  • Employees Stock Option Plan
  • 11-May-21
  • Audited Results
  • 11-Feb-21
  • Quarterly Results

Company Profile

ABOUT Dishman Carbogen Amcis

  • Industry Biotechnology & Drugs
  • ISIN INE385W01011
  • BSE Code 540701
  • NSE Code DCAL

Dishman Carbogen Amcis Limited is engaged in contract research and manufacturing services (CRAMS) and the manufacture and supply of marketable molecules, such as specialty chemicals, vitamins and chemicals, and disinfectants. The Company's segments include CRAMS and Vitamin - D, Bulk Drugs, Quats, Specialty Chemicals and traded goods. The Company assists pharma companies through various stages of drug development from process research and development to late-stage clinical and commercial manufacturing facilities, along with the supply of active pharmaceutical ingredients (APIs) and intermediates. The Company has manufacturing and research facilities in India, Switzerland, France, Netherlands, United Kingdom and China. The Company's subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd., Dishman Carbogen Amcis (Singapore) Pte. Ltd., CARBOGEN AMCIS Holding AG and Dishman Biotech Ltd.

MANAGEMENT

  • Harshil Dalal Global Chief Financial Officer
  • Shrima Dave Compliance Officer, Company Secretary
  • Arpit Vyas Global Managing Director, Executive Director
  • Deohooti Vyas Whole-Time Director

Company Summary

DISHMAN CARBOGEN AMCIS SUMMARY

Dishman Carbogen Amcis is trading 2.31% upper at Rs 97.30 as compared to its last closing price. Dishman Carbogen Amcis has been trading in the price range of 97.5 & 93.7. Dishman Carbogen Amcis has given -52.94% in this year & -6.14% in the last 5 days.

 

Dishman Carbogen Amcis has TTM P/E ratio 295.68 as compared to the sector P/E of 37.72. There are 2 analysts who have initiated coverage on Dishman Carbogen Amcis. There are 0 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.

 

The company posted a net profit of 4.01 Crores in its last quarter.

 

Listed peers of Dishman Carbogen Amcis include Novartis India (-0.14%), Alembic (7.23%), Dishman Carbogen Amcis (2.31%) etc.

FAQs about Dishman Carbogen Amcis

Dishman Carbogen Amcis is trading at 97.30 as on 30 Sep, 2022 3:29:36 PM. This is 2.31% upper as compared to its previous closing price of 95.1
The market capitalization of Dishman Carbogen Amcis is 1487.09 Cr as on 30 Sep, 2022 3:29:36 PM.
The average broker rating on Dishman Carbogen Amcis is Buy. The breakup of analyst rating is given below -
  • 0 analysts have given a strong sell rating
  • 0 analysts have given a sell rating
  • 1 analysts have given a hold rating
  • 1 analysts have given a buy rating
  • 0 analysts have given a strong buy rating
The 52 wk high for Dishman Carbogen Amcis is 259.5 whereas the 52 wk low is 90.2
Dishman Carbogen Amcis can be analyzed on the following key metrics -
  • TTM P/E: 295.68
  • Sector P/E: 37.72
  • Dividend Yield: 0%
  • D/E ratio: -
Dishman Carbogen Amcis reported a net profit of 18.01 Cr in 2022.

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout